Failure patterns relative to radiation treatment fields for stage II-IV thymoma

Journal of Thoracic Oncology

Volumn 9, Issue 3, 2014, Pages 403-409

  Rimner, Andreas ^a   Gomez, Daniel R ^b   Wu, Abraham J ^a   Shi, Weiji ^a   Yorke, Ellen D ^a   Moreira, Andre L ^a   Rice, David ^b   Komaki, Ritsuko ^a   Rosenzweig, Kenneth E ^c   Riely, Gregory J ^a   Huang, James ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Failure pattern; Radiation therapy; Thymoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; PLEURA CAVITY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; THYMECTOMY; THYMOMA; TREATMENT FAILURE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; THYMOMA; THYMUS NEOPLASMS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84894543532     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000099     Document Type: Article

References (26)

1. Berman AT, Litzky L, Livolsi V, et al. Adjuvant radiotherapy for completely resected stage 2 thymoma. Cancer 2011;117:3502-3508.
2. Chen YD, Feng QF, Lu HZ, et al. Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection. Int J Radiat Oncol Biol Phys 2010;78:1400-1406.
3. Utsumi T, Shiono H, Kadota Y, et al. Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer 2009;115:5413-5420.
4. Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT 3rd. Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988;6:1722-1727.
5. Ogawa K, Uno T, Toita T, et al. Postoperative radiotherapy for patients with completely resected thymoma: A multi-institutional, retrospective review of 103 patients. Cancer 2002;94:1405-1413.
6. Weksler B, Shende M, Nason KS, Gallagher A, Ferson PF, Pennathur A. The role of adjuvant radiation therapy for resected stage III thymoma: A population-based study. Ann Thorac Surg 2012;93:1822-8; discussion 1828.
7. Fernandes AT, Shinohara ET, Guo M, et al. The role of radiation therapy in malignant thymoma: A Surveillance, Epidemiology, and End Results database analysis. J Thorac Oncol 2010;5:1454-1460.
8. Patel S, Macdonald OK, Nagda S, Bittner N, Suntharalingam M. Evaluation of the role of radiation therapy in the management of malignant thymoma. Int J Radiat Oncol Biol Phys 2012;82:1797-1801.
9. Forquer JA, Rong N, Fakiris AJ, Loehrer PJ Sr, Johnstone PA. Postoperative radiotherapy after surgical resection of thymoma: Differing roles in localized and regional disease. Int J Radiat Oncol Biol Phys 2010;76:440-445.
10. Sugie C, Shibamoto Y, Ikeya-Hashizume C, et al. Invasive thymoma: Postoperative mediastinal irradiation, and low-dose entire hemithorax irradiation in patients with pleural dissemination. J Thorac Oncol 2008;3:75-81.
11. Gomez D, Komaki R. Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol 2010;5(10 Suppl 4):S336-S343.
12. Gomez D, Komaki R, Yu J, Ikushima H, Bezjak A. Radiation therapy definitions and reporting guidelines for thymic malignancies. J Thorac Oncol 2011;6(7 Suppl 3):S1743-S1748.
13. Chang JH, Kim HJ, Wu HG, Kim JH, Kim YT. Postoperative radiotherapy for completely resected stage II or III thymoma. J Thorac Oncol 2011;6:1282-1286.
14. Huang J, Rizk NP, Travis WD, et al. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg 2009;138:26-31.
15. Wright CD. Stage IVA thymoma: Patterns of spread and surgical management. Thorac Surg Clin 2011;21:93-7, vii.
16. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 2005;130:1413-1421.
17. Utsumi T, Shiono H, Matsumura A, et al. Stage III thymoma: Relationship of local invasion to recurrence. J Thorac Cardiovasc Surg 2008;136:1481-1485.
18. Rea F, Marulli G, Di Chiara F, et al. Multidisciplinary approach for advanced stage thymic tumors: Long-Term outcome. Lung Cancer 2011;72: 68-72.
19. Mangi AA, Wain JC, Donahue DM, Grillo HC, Mathisen DJ, Wright CD. Adjuvant radiation of stage III thymoma: Is it necessary?. Ann Thorac Surg 2005;79:1834-1839.
20. Leibel SA, Fuks Z, Zelefsky MJ, et al. Intensity-modulated radiotherapy. Cancer J 2002;8:164-176.
21. Dirix P, Nuyts S. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncol 2010;11:85-91.
22. Sugarbaker DJ, Gill RR, Yeap BY, et al. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg 2013;145:955-963.
23. Friedberg JS, Culligan MJ, Mick R, et al. Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Ann Thorac Surg 2012;93:1658-65; discussion 1665.
24. Rosenzweig KE, Zauderer MG, Laser B, et al. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2012;83:1278-1283.
25. Minatel E, Trovo M, Polesel J, et al. Tomotherapy after pleurectomy/ decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. J Thorac Oncol 2012;7:1862-1866.
26. Rimner A, Rosenzweig KE. Novel radiation therapy approaches in malignant pleural mesothelioma. Ann Cardiothorac Surg 2012;1:457-461.